ctDNA as a biomarker of progression in oesophageal adenocarcinoma

por Bonazzi, V.F., Aoude, L.G., Brosda, S., Lonie, J.M., Patel, K., Bradford, J.J., Koufariotis, L.T., Wood, S., Smithers, B. Mark, Waddell, N., Barbour, A.P.
Publicado 2022

Complications and survival after hybrid and fully minimally invasive oesophagectomy

por Veenstra, M M K, Smithers, B M, Visser, E, Edholm, D, Brosda, S, Thomas, J M, Gotley, D C, Thomson, I G, Wijnhoven, B P L, Barbour, A P
Publicado 2021

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

por Mercieca-Bebber, R., Barnes, E. H., Wilson, K., Samoon, Z., Walpole, E., Mai, T., Ackland, S., Burge, M., Dickie, G., Watson, D., Leung, J., Wang, T., Bohmer, R., Cameron, D., Simes, J., Gebski, V., Smithers, M., Thomas, J., Zalcberg, J., Barbour, A. P.
Publicado 2022

Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels

por Ramarao-Milne, P., Kondrashova, O., Patch, A.-M., Nones, K., Koufariotis, L.T., Newell, F., Addala, V., Lakis, V., Holmes, O., Leonard, C., Wood, S., Xu, Q., Mukhopadhyay, P., Naeini, M.M., Steinfort, D., Williamson, J.P., Bint, M., Pahoff, C., Nguyen, P.T., Twaddell, S., Arnold, D., Grainge, C., Basirzadeh, F., Fielding, D., Dalley, A.J., Chittoory, H., Simpson, P.T., Aoude, L.G., Bonazzi, V.F., Patel, K., Barbour, A.P., Fennell, D.A., Robinson, B.W., Creaney, J., Hollway, G., Pearson, J.V., Waddell, N.
Publicado 2022